Tuesday, September 16, 2025
HomeIndustriesBiotechnology

Biotechnology

Atossa & Quantum Leap Dose First Patient in I-SPY 2 Trial

Atossa Therapeutics, Inc and Quantum Leap Healthcare Collaborative, announced the first patient has been dosed in their clinical trial evaluating Atossa’s proprietary (Z)-endoxifen in...

Crown Bioscience & CTI Collaborate on Oncology Drug Consulting

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced a strategic partnership with Clinical Trial & Consulting Services...

Bio-Rad Appoints Jon DiVincenzo President, COO

Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostics products, announced that Jon DiVincenzo will join the company as President...

Actio Biosciences Appoints Dimitrios Arkilo, M.D as CMO

Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology...

Mission Bio’s Tapestri Advances Gene-Edited T-Cell Therapy

Mission Bio, a leader in single-cell multiomics solutions for precision medicine, announced the release of data from scientists at Genentech’s Analytical Development Group, showcasing...
0FansLike
0FollowersFollow
spot_img

Hot Topics